Media Room--We can provide journalists with expert commentary on topics like:  

  • Challenges facing early career scientists, and new technologies and trends in cancer research (all forms of cancer)
  • Connections to bright, articulate early career scientists involved in leading-edge cancer research projects
  • Introductions to scientists and doctors nationwide, and interviews with our President and CEO, Chief Scientific Officer, or others

Contact: Peter Cleary, Director of Communications 212.455.0504 or 347.322.9695, email peter.cleary@damonrunyon.org 

Press releases listed below, and visit New Discoveries for breakthroughs from our scientists.

Mission: To accelerate breakthroughs, the Damon Runyon Cancer Research Foundation provides today’s best young scientists with funding to pursue innovative cancer research. The Foundation supports emerging leaders who have great potential to achieve breakthroughs in how we diagnose, treat and prevent cancer. Since its founding in 1946, the Foundation has invested over $320 million and funded more than 3,550 young scientists. 100% of all donations to the Foundation are used to support scientific research. 

July 26, 2017

New York, NY (July 26, 2017) – The Damon Runyon Cancer Research Foundation has named four outstanding young scientists as recipients of the prestigious Damon Runyon-Sohn Pediatric Cancer Fellowship Award, committing nearly $1 million to help address a critical shortage of funding for pediatric cancer research.


July 14, 2017

The Damon Runyon Cancer Research Foundation named 18 new Damon Runyon Fellows at its spring Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Fellowship encourages the nation's most promising young scientists to pursue careers in cancer research by providing them with independent funding to work on innovative projects that have the potential to impact cancer prevention, diagnosis, and treatment.


July 3, 2017

The Damon Runyon Cancer Research Foundation named five new Damon Runyon Clinical Investigators at its spring 2017 Clinical Investigator Award Committee review. The recipients of this prestigious three-year award are outstanding early career physician-scientists conducting patient-oriented cancer research at major research centers under the mentorship of the nation’s leading scientists and clinicians. The Foundation also awarded Continuation Grants to three Damon Runyon Clinical Investigators. The Continuation Grant is designed to support Clinical Investigators who are approaching the end of their original awards and need extra time and funding to complete a promising avenue of research or initiate/continue a clinical trial.


June 30, 2017

To help increase the number of physician-scientists, the Damon Runyon Cancer Research Foundation has created the new Damon Runyon Physician-Scientist Training Award, which provides physicians who have earned an MD degree and completed clinical specialty fellowship training the opportunity to gain the research experience they need to become leaders in translational and clinical research. Damon Runyon announced that four scientists with novel approaches to fighting cancer have been named the 2017 recipients of the award.


May 24, 2017

BRONX, New York – May 24, 2017 –  On Saturday, July 15, 2017, the Damon Runyon Cancer Research Foundation will hold the 9th Annual Runyon 5K at Yankee Stadium – and 100 percent of funds raised will directly support innovative cancer research by brilliant, early career scientists.

May 23, 2017

SAN FRANCISCO – May 17, 2017 – The Damon Runyon Cancer Research Foundation hosted a benefit performance of the Broadway musical HAMILTON on Tuesday, May 16, 2017, at the SHN Orpheum Theatre in San Francisco, raising almost $1 million for innovative cancer research.

March 6, 2017

Today, the Damon Runyon Cancer Research Foundation held the sixth annual Accelerating Cancer Cures Research Symposium. The yearly meeting is designed to encourage collaboration between cancer researchers in industry and their counterparts in academia in order to overcome many of the issues that currently impede progress against cancer.  Hosted this year by Novartis, the meeting included academic researchers from top universities and research institutions as well as scientists from Celgene, Eli Lilly and Company, Genentech, Merck, and Novartis.


January 11, 2017

The Damon Runyon Cancer Research Foundation, a non-profit organization focused on supporting innovative early career researchers, named 16 new Damon Runyon Fellows at its fall Fellowship Award Committee review. The recipients of this prestigious, four-year award are outstanding postdoctoral scientists conducting basic and translational cancer research in the laboratories of leading senior investigators across the country. The Committee also named three new recipients of the Damon Runyon-Dale F. Frey Award for Breakthrough Scientists.


January 5, 2017

The Damon Runyon Cancer Research Foundation announced that nine scientists with novel approaches to fighting cancer have been named 2017 recipients of the Damon Runyon-Rachleff Innovation Award. The Award funds cancer research by exceptionally creative thinkers with “high-risk/high-reward” ideas who lack sufficient preliminary data to obtain traditional funding. The awardees are selected through a highly competitive and rigorous process by a scientific committee comprised of leading cancer researchers who are innovators themselves. Only those scientists with a clear vision and passion for curing cancer are selected to receive the prestigious award. 


September 26, 2016

The Damon Runyon-Jake Wetchler Award for Pediatric Innovation will be given annually to a third-year Damon Runyon Fellow whose research has the greatest potential to impact the prevention, diagnosis, or treatment of one or more forms of pediatric cancer.  The first Award was given to Mark W. Zimmerman, PhD, a Damon Runyon-Sohn Fellow at Dana-Farber Cancer Institute and was presented by members of The Jake Wetchler Foundation for Innovative Pediatric Cancer Research. It is a $5,000 prize with no restrictions on its use.